Germline CDH1 mutations in bilateral lobular carcinoma in situ

[1]  A. Sézeur,et al.  CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study , 2013, Journal of Medical Genetics.

[2]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[3]  Janice S. Sung,et al.  Screening breast MR imaging in women with a history of lobular carcinoma in situ. , 2011, Radiology.

[4]  Y. Bignon,et al.  Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer , 2011, Cancer.

[5]  O. Olopade,et al.  Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers , 2010, Journal of Medical Genetics.

[6]  C. Caldas,et al.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research , 2010, Journal of Medical Genetics.

[7]  Yoko Ito,et al.  Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer , 2008, The Journal of pathology.

[8]  P. Miron,et al.  Germline E-cadherin mutations in familial lobular breast cancer , 2007, Journal of Medical Genetics.

[9]  B. Fernandez,et al.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.

[10]  E. Morris,et al.  Results of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia , 2007, Annals of Surgical Oncology.

[11]  L. Ford,et al.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.

[12]  R. Severson,et al.  Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  D. Huntsman,et al.  Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management , 2005, Clinical Cancer Research.

[14]  P. Bult,et al.  The Role of MRI in Invasive Lobular Carcinoma , 2004, Breast Cancer Research and Treatment.

[15]  W. Foulkes,et al.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.

[16]  Norman Wolmark,et al.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project , 2004, Cancer.

[17]  C Caldas,et al.  Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. , 2001, Gastroenterology.

[18]  R. Roylance,et al.  Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast , 2001, International journal of cancer.

[19]  S. Seal,et al.  Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene , 2000, British Journal of Cancer.

[20]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[21]  W. Thompson,et al.  Relationship between breast histopathology and family history of breast cancer , 1993, Cancer.